(Schaumburg, IL. July 1, 2014). Glen Weiss, MD, MBA, Director of Clinical Research and Phase I & II Clinical Trials for Cancer Treatment Centers of America® (CTCA) at Western Regional Medical Center (Western), presented a guest seminar at the Weizmann Institute of Science in Rehovot, Israel on June 18. The Weizmann Institute of Science is an internationally recognized Israeli university that is highly regarded within the scientific community for its multidisciplinary research and graduate studies in the natural and exact sciences. Dr. Weiss’ seminar, Precision Medicine in Oncology, was delivered to the Weizmann Institute’s Department of Biological Regulation.
Dr. Weiss provided in-depth information on the role of precision medicine in cancer care, an oncology advancement that is designed to find individualized treatment options for patients by examining the genetic profile of their cancer tumor. His detailed knowledge of precision medicine and its application in the treatment of cancer is a result of his involvement in research and clinical trial programs. Dr. Weiss' seminar specifically focused on genomics and other ‘omics assays, their significance in clinical research, and the importance of focused, well-designed trials.
“Cancer Treatment Centers of America is at the forefront of utilizing precision medicine for advanced complex cancers and implementing it in clinical research endeavors, and it was an honor to speak on behalf of my colleagues to such an esteemed group,” said Dr. Weiss.
In addition to his role at Cancer Treatment Centers of America, Dr. Weiss also serves as Co-Head of the Lung Cancer Unit and Clinical Associate Professor at the Translational Genomics Research Institute (TGen). Certified in medical oncology by the American Board of Internal Medicine, he specializes in developing personalized therapies for patients with advanced cancer types. Dr. Weiss earned his medical degree from the Sackler School of Medicine in Tel Aviv, Israel, as well as a Master of Business Administration from the W.P. Carey School of Business at Arizona State University. In addition to the Weizmann Institute, he has presented at institutions around the globe, including Seoul, Korea; Orleans, France; Vienna, Austria; and Budapest, Hungary.
About Cancer Treatment Centers of America®
Cancer Treatment Centers of America® (CTCA), headquartered in Boca Raton, Fla., is a national network of five hospitals that serves adult patients who are fighting cancer. CTCA® offers an integrative approach to care that combines advancements in genomic testing and precision cancer treatment, surgery, radiation, immunotherapy and chemotherapy, with evidence-based complementary therapies that support patients physically and emotionally, enhancing their quality of life while reducing side effects both during and after treatment. CTCA serves patients from around the world at its hospitals in Atlanta, Chicago, Philadelphia, Phoenix and Tulsa. Consistently rated among U.S. hospitals that deliver the highest quality of care and patient experience, CTCA provides patients and their families with comprehensive information about their treatment options and encourages their active participation in treatment decisions. For more information, visit cancercenter.com, Facebook.com/cancercenter and Twitter.com/cancercenter.